Cargando…
Giant osteoclasts in patients under bisphosphonates
BACKGROUND: Bisphosphonates have been widely used for treatment of high bone resorption states. It lowers bone turnover by inhibiting osteoclasts bone resorption with various mechanisms of actions: inhibition of osteoclast formation and attachment to the bone surface, induction of metabolic injury,...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094788/ https://www.ncbi.nlm.nih.gov/pubmed/25024641 http://dx.doi.org/10.1186/1472-6890-14-31 |
_version_ | 1782325902304083968 |
---|---|
author | Mac-Way, Fabrice Trombetti, Andrea Noel, Christian Lafage-Proust, Marie-Hélène |
author_facet | Mac-Way, Fabrice Trombetti, Andrea Noel, Christian Lafage-Proust, Marie-Hélène |
author_sort | Mac-Way, Fabrice |
collection | PubMed |
description | BACKGROUND: Bisphosphonates have been widely used for treatment of high bone resorption states. It lowers bone turnover by inhibiting osteoclasts bone resorption with various mechanisms of actions: inhibition of osteoclast formation and attachment to the bone surface, induction of metabolic injury, alteration of vesicle trafficking and induction of osteoclast apoptosis. Bone biopsies studies from patients under bisphosphonates have shown that some resorption parameters are decreased as expected but the number of osteoclasts seems not to be necessarily decreased. The description of osteoclasts morphology from patients treated with bisphosphonates has rarely been reported in the literature. CASE PRESENTATION: We describe in this paper two patients treated with bisphosphonates from whom iliac crest bone biopsies have shown large, multinucleated and apoptotic osteoclasts that were not associated with bone resorption activities. The characteristics of these osteoclasts are described and the literature reviewed. CONCLUSION: The appropriate recognition of these giant osteoclasts in bone tissues from patients treated with bisphosphonates is of primary importance for bone pathologists and should not be interpreted as signs of increased bone resorption as seen in hyperparathyroidism, bone cancer or Paget’s disease of bone. |
format | Online Article Text |
id | pubmed-4094788 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-40947882014-07-15 Giant osteoclasts in patients under bisphosphonates Mac-Way, Fabrice Trombetti, Andrea Noel, Christian Lafage-Proust, Marie-Hélène BMC Clin Pathol Case Report BACKGROUND: Bisphosphonates have been widely used for treatment of high bone resorption states. It lowers bone turnover by inhibiting osteoclasts bone resorption with various mechanisms of actions: inhibition of osteoclast formation and attachment to the bone surface, induction of metabolic injury, alteration of vesicle trafficking and induction of osteoclast apoptosis. Bone biopsies studies from patients under bisphosphonates have shown that some resorption parameters are decreased as expected but the number of osteoclasts seems not to be necessarily decreased. The description of osteoclasts morphology from patients treated with bisphosphonates has rarely been reported in the literature. CASE PRESENTATION: We describe in this paper two patients treated with bisphosphonates from whom iliac crest bone biopsies have shown large, multinucleated and apoptotic osteoclasts that were not associated with bone resorption activities. The characteristics of these osteoclasts are described and the literature reviewed. CONCLUSION: The appropriate recognition of these giant osteoclasts in bone tissues from patients treated with bisphosphonates is of primary importance for bone pathologists and should not be interpreted as signs of increased bone resorption as seen in hyperparathyroidism, bone cancer or Paget’s disease of bone. BioMed Central 2014-07-08 /pmc/articles/PMC4094788/ /pubmed/25024641 http://dx.doi.org/10.1186/1472-6890-14-31 Text en Copyright © 2014 Mac-Way et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Case Report Mac-Way, Fabrice Trombetti, Andrea Noel, Christian Lafage-Proust, Marie-Hélène Giant osteoclasts in patients under bisphosphonates |
title | Giant osteoclasts in patients under bisphosphonates |
title_full | Giant osteoclasts in patients under bisphosphonates |
title_fullStr | Giant osteoclasts in patients under bisphosphonates |
title_full_unstemmed | Giant osteoclasts in patients under bisphosphonates |
title_short | Giant osteoclasts in patients under bisphosphonates |
title_sort | giant osteoclasts in patients under bisphosphonates |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094788/ https://www.ncbi.nlm.nih.gov/pubmed/25024641 http://dx.doi.org/10.1186/1472-6890-14-31 |
work_keys_str_mv | AT macwayfabrice giantosteoclastsinpatientsunderbisphosphonates AT trombettiandrea giantosteoclastsinpatientsunderbisphosphonates AT noelchristian giantosteoclastsinpatientsunderbisphosphonates AT lafageproustmariehelene giantosteoclastsinpatientsunderbisphosphonates |